CDDF multi-stakeholder workshop (June 2017)

Innovation in Oncology Clinical Trial Design

Frankfurt, Germany, 12 & 13 June 2017

Final banner - Clinical Trials workshop

The CDDF multi-stakeholder workshop on Innovation in Oncology Clinical Trial Design aimed at discussing clinical trial study designs for oncology with current and recent challenges together with a multi-stakeholder audience of experts from academia, regulatory authorities, pharmaceutical industry and patient advocate groups.

The objective of the workshop was to:

  • better understand the position and concerns of the other stakeholders to ensure better study designs can be developed for more efficient drug development
  • to have a multi-stakeholder discussion representing oncologists/scientists, government officials (EMA, policymakers and HTA), pharmaceutical industry representatives and patient advocate groups interested in the topic.

PROGRAMME COMMITTEE

  • Jaap Verweij (Erasmus MC)
  • Kinga Komar Malinowska (Bayer)
  • Stefan Schwoch (Lilly)
  • Irmela Radtke (F. Hoffmann La Roche Ltd)
  • Jan Gross (Merckgroup)

SCIENTIFIC PROGRAMME

Final CDDF Workshop June 17 Programme

SPEAKERS’ PRESENTATIONS

To access the slides, please click here

twitter32x32Join the discussion on Twitter by using #CDDFworkshop